Digital Conferences - On Wednesday December 4th, 2024 PropThink hosted a live webinar with 3 incredible Key Opinion Leaders (“KOLs”) to discuss Duchenne Muscular Dystrophy (“DMD”) and learn … Continue Reading
Read nowInsights - The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns to that of checkpoint inhibitors … Continue Reading
Read nowInsights - One of the names we wrote about back in mid-December as a trade due to its ample cash position and negative enterprise value was Mural … Continue Reading
PremiumInsights - In a prior note, we covered the impact that GLP-1 drug class would have on related markets. On this note, we’ll focus on NASH (now … Continue Reading
Read nowInsights - Participants PropThink Dr. Michael Chancellor, KOL Jonathan Kaufman, Lipella CEO PropThink Good afternoon everyone, welcome to PropThink’s Digital Conference. My name is Deniel Mero, Editor … Continue Reading
Read nowInsights - Modular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately six months to approve devices … Continue Reading
PremiumInsights - Biotech has roared back and seen a strong start to the new year. Since November, in less than 3 months, the XBI is up 32%. … Continue Reading
Read now
